Table 3 Characteristics of 242 children in the Nordic JIA cohort according to PE participation at the 8 year visita
Characteristics at the eight-year visit | Total n | Full PE (n = 194) | Partly or no PE (n = 48) | OR (95% CI) | P-value |
|---|---|---|---|---|---|
Females, n (%) | 242 | 119 (61.3) | 39 (81.3) | 2.7 (1.3–6.0) | 0.012 |
Age at disease onset, years | 242 | 4.4 (2.2–7.3) | 4.6 (2.3–8.7) | 1.0 (0.9–1.1) | 0.398 |
BMI | 205 | 18.9 (16.8–21.0) | 21.2 (17.8–23.5) | 1.1 (1.0–1.2) | 0.013 |
Cumulative joint count | 242 | 5 (2–9) | 12 (4–16) | 1.1 (1.0–1.1) | < 0.001 |
Active joints | 242 | 0 (0–0) | 0 (0–2) | 2.0 (1.4–2.8) | < 0.001 |
Physician GA, VAS | 188 | 0.0 (0.0–0.5) | 0.9 (0.2–2.0) | 7.1 (2.7–18.8) | < 0.001 |
Patient/parent GA, VAS | 212 | 0.0 (0.0–0.4) | 1.6 (0.3–3.4) | 6.1 (2.9–12.6) | < 0.001 |
Pain VAS | 216 | 0.0 (0.0–0.5) | 2.0 (0.8–5.6) | 7.8 (3.8–15.9) | < 0.001 |
CHAQ score | 242 | 0.0 (0.0–0.0) | 0.3 (0.0–1.0) | 15.0 (5.9–38.6) | < 0.001 |
CHQ-PF50, PhS score | 156 | 53.9 (48.5–57.3) | 41.5 (31.1–48.2) | 0.9 (0.8–0.9) | < 0.001 |
CHQ-PF50, PsS score | 156 | 56.0 (49.9–60.1) | 50.3 (44.6–55.8) | 0.9 (0.9–1.0) | 0.010 |
DMARDs, n (%) | 242 | 64 (33.0) | 24 (50.0) | 1.5 (1.1–2.2) | 0.025 |
JADAS10 | 147 | 0.1 (0.0–1.9) | 4.7 (1.9–8.0) | 1.5 (1.3–1.7) | < 0.001 |
Not in remission, n (%) | 236 | 106 (55.8) | 42 (91.3) | 6.5 (2.5–17.2) | < 0.001 |
ESR mm/hour | 164 | 7.0 (4.0–10.0) | 12.0 (5.0–16.0) | 1.1 (1.0–1.1) | 0.029 |
CRP mg/liter | 169 | 0.0 (0.0–5.0) | 0.0 (0.0–5.0) | 1.0 (0.9–1.0) | 0.851 |
RF positive, n (%) | 123 | 1.0 (1.1) | 0 | n.a | n.a |
HLA-B27 positive, n (%) | 233 | 42 (22.6) | 10 (21.3) | 0.9 (0.4–2.0) | 0.848 |
ANA positive, n (%) | 241 | 51 (26.4) | 8 (16.7) | 0.6 (0.2–1.3) | 0.164 |